Ascent Industries Co. completed its transition to a pure-play Specialty Chemicals business in Q3 2025 following the April and June divestitures of BRISMET and ASTI, which are reported as discontinued operations.
Financial Performance (Continuing Operations): Q3 Net Sales were \(19.7M (down 5.7% YoY), with nine-month sales at \)56.2M (down 10.3%). However, gross margins expanded significantly due to lower raw material costs, resulting in a Q3 margin of 29.7% and a nine-month margin of 24.5%. The operating loss narrowed to \(0.8M in Q3 (from \)2.0M in 2024). Cash flow from continuing operations
...